You just read:

DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma ("GBM") at SNO's Pediatric Neuro-Oncology Basic and Translational Research Conference

News provided by

DelMar Pharmaceuticals, Inc.

Jun 16, 2017, 08:30 ET